Damluji, MD, PhD, MBA Mineralocorticoid Receptor Overactivation in Heart Failure with Preserved Ejection Fraction Aug 3, 2026 Mineralocorticoid Receptor Overactivation in Heart Failure with Preserved Ejection Fraction Heart failure with preserved ejection fraction has become one of the most common forms of heart failure, with a Outcomes After Percutaneous Coronary Intervention for Chronic Coronary Disease in Adults Aged 75 Years or Older Compared With Younger Adults Aug 1, 2026 Outcomes After Percutaneous Coronary Intervention for Chronic Coronary Disease in Adults Aged 75 Years or Older Compared With Younger Adults Chronic coronary disease is a frequent cause of illness and death in older adults, and percutaneous coronary Treadmill Stress Testing in Asymptomatic Severe Aortic Stenosis: Safe, Informative, and Underused Jul 26, 2026 Treadmill Stress Testing in Asymptomatic Severe Aortic Stenosis: Safe, Informative, and Underused Aortic stenosis is among the most frequent valve diseases in older adults, and roughly half of patients have no Midlife Cardiorespiratory Fitness and the Compression of Late Life Disease Jul 25, 2026 Midlife Cardiorespiratory Fitness and the Compression of Late Life Disease Cardiorespiratory fitness is an objective measure of the functional capacity of the heart, lungs, and circulation, and Caffeine and Cardiovascular Disease: What the American Heart Association Scientific Statement Means for Practice Jul 20, 2026 Caffeine and Cardiovascular Disease: What the American Heart Association Scientific Statement Means for Practice Caffeine is among the most commonly consumed drugs in the world, and clinicians are asked about it more often than Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease: The DAPT-MVD Trial Jul 19, 2026 Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease: The DAPT-MVD Trial The optimal duration of antiplatelet treatment after coronary stenting in patients with multivessel coronary artery Placebo-Controlled Evidence That Opening a Chronic Total Occlusion Relieves Angina: The ORBITA-CTO Trial Jul 13, 2026 Placebo-Controlled Evidence That Opening a Chronic Total Occlusion Relieves Angina: The ORBITA-CTO Trial Percutaneous coronary intervention for a coronary chronic total occlusion is performed routinely to relieve angina and Revised Lipid Lowering Therapy Guidelines and the Reclassification of United States Adults Jul 6, 2026 Revised Lipid Lowering Therapy Guidelines and the Reclassification of United States Adults Thought process Thought process Revised Lipid Lowering Therapy Guidelines and the Reclassification of United States Blood Aldosterone Concentrations and the Effects of Mineralocorticoid Receptor Antagonists in Heart Failure Jul 5, 2026 Blood Aldosterone Concentrations and the Effects of Mineralocorticoid Receptor Antagonists in Heart Failure Aldosterone is the terminal hormone of the renin angiotensin aldosterone system and acts through the mineralocorticoid Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Trial Jul 4, 2026 Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Trial Patients with diabetes mellitus frequently present with multivessel coronary artery disease as a consequence of Others also viewed Explore content categories
00243-1/asset/3e6344be-cfd8-4182-b471-5c447dcc78dd/main.assets/gr1_lrg.jpg)
These medications are powerful prescription tools
For those who have struggled to shed pounds and keep them off, Semaglutide offers a groundbreaking solution
The repair and regeneration of nerve fibers is a long process